Chartered Group
VC Fund
Chartered Group is a VC fund focused on Artificial Intelligence and Apps. The Chartered Group is an investment platform.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 82%
Last updated:
For AI agents: llms.txt
Industries Chartered Group invests in
Stages Chartered Group invests in
Countries Chartered Group invests in
Round sizes
Round size
- Series A
- $5M–$22M
- Venture - Series Unknown
- $2.6M–$10M
Investment Focus
Industry
- Artificial Intelligence 3 (27%)
- Apps 1 (9%)
- Drones 1 (9%)
- Hardware 1 (9%)
- Software 1 (9%)
Stage
- Series A 4 (36%)
- Venture - Series Unknown 3 (27%)
- Seed 1 (9%)
- Series B 1 (9%)
- Private Equity 1 (9%)
Country
- Israel 4 (36%)
- United States 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| XTEND develops AI-assisted tactical Unmanned Aircraft Systems (UAS) and the XOS operating system for remote operations. Its platforms are designed for military, security, and industrial applications, enabling intuitive control and rapid deployment. XTEND's technology supports multi-platform control, exchangeable payloads, and integration withthird-party software for diverse mission needs. | $30M / Series B / Jul 15, 2025 | ||
| CogniFiber designs and builds stand-alone photonic AI accelerators for IoT analytics based on proprietary photonic deep learning processors. | $5M / Venture - Series Unknown / Jul 04, 2024 | ||
| XTEND develops AI-assisted tactical Unmanned Aircraft Systems (UAS) and the XOS operating system for remote operations. Its platforms are designed for military, security, and industrial applications, enabling intuitive control and rapid deployment. XTEND's technology supports multi-platform control, exchangeable payloads, and integration withthird-party software for diverse mission needs. | $40M / Series B / May 08, 2024 | ||
| Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use. | $15M / Private Equity / Mar 01, 2022 | ||
| CogniFiber designs and builds stand-alone photonic AI accelerators for IoT analytics based on proprietary photonic deep learning processors. | $6M / Series A / Feb 09, 2022 | ||
| Ridge, the world’s most distributed cloud, unlocks the full potential of cloud computing. Its massive network of points of presence closes public cloud coverage gaps and empowers businesses to deploy applications on existing infrastructure anywhere — with no latency or data residency obstacles. Ridge’s cloud-native services, including itsCNCF-certified managed Kubernetes, are simple for DevOps and cloud architects to operate. They enable them to easily deploy cloud-native applications as part of any multi-cloud or hybrid cloud architectures. With Ridge, developers enjoy public cloud agility together with the superior performance, high throughput, and data control of private servers. | $22M / Series A / Jan 25, 2022 | ||
| XTEND develops AI-assisted tactical Unmanned Aircraft Systems (UAS) and the XOS operating system for remote operations. Its platforms are designed for military, security, and industrial applications, enabling intuitive control and rapid deployment. XTEND's technology supports multi-platform control, exchangeable payloads, and integration withthird-party software for diverse mission needs. | $20M / Series A / Nov 16, 2021 | ||
| Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators. | $2.6M / Venture - Series Unknown / Mar 09, 2021 | ||
| Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators. | $5M / Series A / Oct 24, 2019 | ||
| Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use. | $10M / Venture - Series Unknown / Feb 27, 2019 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chartered Group invest in?
Chartered Group invests primarily in Artificial Intelligence, Apps and Drones startups, most often at Series A and Venture - Series Unknown stage. Most of the 11 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Chartered Group invest in?
Chartered Group typically joins rounds of $5M–$22M at Series A and $2.6M–$10M at Venture - Series Unknown. These are whole funding-round sizes, not Chartered Group's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Chartered Group took part in.
When did Chartered Group last invest?
The most recent investment recorded for Chartered Group closed in Jul 2025. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
